Navigation Links
Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
Date:2/3/2009

al results, will better position us to secure an optimal partnership arrangement for R788," said James M. Gower, Chairman and Chief Executive Officer. As for the program cuts, Mr. Gower said, "Rigel has been blessed with a prolific research organization whose members are dedicated and talented professionals. However, we have come to the point in time, where we can no longer continue to support all of the programs we have generated. The company needs to focus on moving our most advanced projects forward, including, in the case of R788, potentially into Phase 3 clinical trials."

Update on the Phase 2b, TASKi2 and TASKi3, Clinical Trials:

Enrollment for the TASKi2 clinical trial of R788 in patients with rheumatoid arthritis (RA) who have previously failed to respond to methotrexate treatment was completed in December 2008, with 457 patients randomized. The smaller TASKi3 clinical trial of R788 is on track to complete enrollment in April 2009 with an expected enrollment of 195 patients with RA who have previously failed to respond to at least one marketed biologic treatment. Both clinical trials are multi-center, randomized, double-blind, and placebo controlled.

The primary objectives for TASKi2 and TASKi3 are to measure the efficacy of R788 at 6 months and 3 months, respectively, as determined by ACR20 scores (American College of Rheumatology responder rates showing a minimum of 20% improvement in RA symptoms and pain). Secondary objectives will include comparing higher ACR response rates (ACR 50 and ACR 70), as well as DAS28 rates (Disease Activity Score including a 28-joint inspection), in addition to various safety measures. TASKi3 will also include measurement of changes in bone morphology using magnetic resonance imaging (MRI) scans as a secondary measure. In addition, Rigel will continue to develop R788 in various lymphomas and is currently conducting a clinical trial in T-cell lymphoma.'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
2. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
3. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
6. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
8. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
9. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
10. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... SHANGHAI , June 30, 2015 Today, ... officially signed an agreement with Chengdu Tianyi Exhibition Co., ... West , which is to be held concurrently with ... member to UBM,s healthcare exhibition family, following MEDTEC China ... equipment exhibition market in west China. It,s also another ...
(Date:6/30/2015)... -- July 4 th is this weekend, a time we ... people behind it. To help honor our current nation,s heroes, ... Medical Card, a leading provider of free pharmacy ... independence for our disabled military veterans, police, firemen, and EMS ... prescriptions. "Due to USA ...
(Date:6/30/2015)... RESEARCH TRIANGLE PARK, N.C. , June 30, 2015 ... solutions and services to the life sciences industry, has ... first direct to patient shipment of clinical drug product ... in South Korea to continue ... Middle East Respiratory System (MERS). The emergency ...
Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
... According to an overview of industry data released ... , in Fiscal Year 2011, pharmaceutical companies continued a ... delay the introduction of lower-cost prescription drug alternatives for ... that drug companies entered into 28 potential pay-for-delay ...
... ABAXIS, Inc. (NasdaqGS: ABAX), a medical products company manufacturing ... the second fiscal quarter ended September 30, 2011. ... $40.0 million, up 13% over last year,s comparable quarter. ... over last year,s comparable quarter. Veterinary market sales ...
Cached Medicine Technology:FTC Study Finds that in FY 2011, Pharmaceutical Industry Continued to Make Numerous Business Deals that Delay Consumers' Access to Lower-Cost Generic Drugs 2FTC Study Finds that in FY 2011, Pharmaceutical Industry Continued to Make Numerous Business Deals that Delay Consumers' Access to Lower-Cost Generic Drugs 3Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 2Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 3Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 4Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 5Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 6Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 7Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 8Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012 9
(Date:6/30/2015)... ... June 30, 2015 , ... The Citizens ... Danny Davis (D-IL) for writing to the Department of Health and Human Services ... behavioral healthcare system, Universal Health Services (UHS).[1] CCHR is expanding its seven-year review ...
(Date:6/30/2015)... ... June 30, 2015 , ... India Network Foundation today announced ... its visitor health insurance plans that provides coverage for visitors to the United States. ... enable visitors to obtain services from most experienced health care professional close to their ...
(Date:6/30/2015)... ... 2015 , ... The League for Innovation in the Community ... Predictive Analytics Reporting (PAR) Framework, and Susan Rundell Singer, Director of the Division ... at the 2015 STEMtech conference in Phoenix, Arizona, November 1-4. , Opening ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... advanced protection at less thickness than any other padding in football. , Developed ... protection and shock absorption, Gameday Armour is engineered with D3O protective polymer. This ...
(Date:6/30/2015)... ... June 30, 2015 , ... Amerec, a division of TyloHelo Inc, is ... AEC Daily is now approved by the Interior Design Continuing Education Council for 1 ... an overview and explanation of what sauna, steam, and far-infrared saunas are, where they ...
Breaking Medicine News(10 mins):Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 2Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:Amerec’s Steam and Sauna Continuing Education Course Now Approved for Interior Design Credit 2
... memory could offer an early warning system for Alzheimer ... Rush University Medical Center. The researchers have found// that ... in the brain related to Alzheimer's disease. Their findings ... ,The researchers looked at the association between ...
... found out that a protein called NMNAT can delay the ... level. The researchers from Baylor College of// Medicine in a ... online today said that NMNAT protects against nerve cell degeneration ... the question if a drug might be developed that could ...
... a International Labor Organization (ILO) report issued on Dec 1 ... to work partially or fully due to// HIV and million ... added that the virus had a crippling effect on the ... virus has among children has threatened the future working generations ...
... wines that belong to the vineyards of France and Italy are ... effects of fatty meals on the heart can be offset by ... has shown. Wines from these regions contain high levels of a ... have also proved the heart healthy benefits of a daily glass ...
... at the time of vaccination may reduce the effectiveness of ... is vaccinated, the goal is to produce as many antibodies ... EurekAlert. ,To do this, white blood cells (B ... defend the body against infections spring into action to produce ...
... and colleagues at four other medical centers have launched ... may contribute to early atherosclerosis. ,“If we can ... who have a genetic predisposition to develop atherosclerosis, we ... stroke sooner and more aggressively,” said David Herrington, M.D., ...
Cached Medicine News:Health News:Memory Complaints Are Associated With Alzheimer's Disease 2Health News:Memory Complaints Are Associated With Alzheimer's Disease 3Health News:NMNAT Protein Protects Against Nerve Cell Degeneration 2Health News:ILO Reports On The Crippling Effects Of HIV On The Workforce 2Health News:Study Underway to Identify Genes Contributing to Heart Attack Risk 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: